| 1. Domain | 1.1 Scope of the Domain | Boundaries | The range of phenomena the science includes and excludes. | Studies the biochemical composition, structure, dynamics, and functions of biological membranes, including lipid organization, membrane proteins, transport, signaling, trafficking; excludes purely structural biology without membrane context or intracellular biochemistry unrelated to membrane interfaces. |
| | Scale | The spatial, temporal, or organizational level at which the science operates (e.g., quantum, cellular, social, cosmic). | Operates from atomic interactions in lipid tails and protein helices to nanoscale bilayer domains, whole-membrane mechanics, organelle-scale membrane systems, and cell-wide membrane-trafficking networks. |
| 1.2 Ontological Commitments | Entities | The kinds of things assumed to exist within the domain (particles, organisms, agents, fields, etc.). | Lipids (phospholipids, sphingolipids, sterols), membrane proteins (channels, pumps, receptors), lipid rafts, vesicles, transporters, anchors, glycoconjugates, curvature-inducing proteins, ion gradients. |
| | Properties | The fundamental attributes these entities possess (mass, charge, genotype, preference, etc.). | Fluidity, curvature, charge asymmetry, thickness, permeability, lateral diffusion, phase behavior, lipid composition, protein insertion topology, membrane potential, elastic modulus, domain formation propensity. |
| | Categories | The basic ontological types used to classify domain elements (substances, processes, relations, structures). | Membrane types (plasma membrane, ER, Golgi, mitochondrial inner membrane, lysosomal), lipid classes, membrane-protein classes (integral, peripheral, GPI-anchored), transport mechanisms (channels, carriers, pumps). |
| 1.3 State-Variables | Variables | The measurable or definable properties that describe system conditions. | Membrane potential (ΔΨ), pH of compartments, ion gradients, lateral lipid composition, membrane tension, curvature, protein conformational state, cholesterol content, diffusion rates, local domain size. |
| | Parameterization | How variables encode and represent the system’s state. | States encoded via lipidomics profiles, protein occupancy, membrane-potential values, transport kinetics, FRAP diffusion constants, curvature metrics, phase-transition temperatures, permeability coefficients. |
| 1.4 Admissible Idealizations | Simplifications | Conceptual reductions used to make the domain tractable (point masses, rational agents, perfect gases). | Treating membranes as homogeneous bilayers, assuming symmetric leaflets, ignoring lipid–protein cooperativity, using 2-state protein-switching models, idealized raft domains, ignoring molecular crowding or cytoskeletal coupling. |
| | Validity Conditions | The limits and contexts in which idealizations hold or break down. | Valid for simplified model membranes or purified proteins; breaks down in crowded cellular membranes, asymmetrical leaflets, strong curvature, raft microdomains, high protein density, or rapid trafficking states. |
| 1.5 Domain Assumptions | Structural Assumptions | Background ontological stances such as determinism, continuity, randomness, discreteness. | Membrane architecture determines function; lipid–protein interactions are fundamental; gradients drive transport; dynamic remodeling occurs under regulated biochemical control. |
| | Implicit Commitments | Unstated but necessary assumptions that shape the field’s conceptual structure. | Assumes definable membrane domains, stable lipid–protein composition under given conditions, interpretable diffusion/transport behavior, reliable mapping between membrane composition and function. |
| 1.6 Internal Coherence Requirements | Consistency | The demand that domain concepts do not contradict one another. | Requires consistency among lipid composition, membrane curvature, protein distribution, transport kinetics, signaling behavior, and structural dynamics. |
| | Compatibility | The requirement that entities, variables, and assumptions fit together into a unified descriptive framework. | Demands alignment between membrane structure, lipid biochemistry, transport processes, signaling systems, organelle identity, and trafficking pathways within a unified membrane framework. |
| 2. Evidence Layer | 2.1 Observable Phenomena | Observables | The aspects of the domain that can produce detectable signals accessible to measurement. | Fluorescence intensity changes in membranes, lipid-phase transitions, FRAP recovery curves, membrane-potential shifts, Ca²⁺/ion flux signals, curvature changes, vesicle budding/fusion, protein relocalization, lipid-domain formation, permeability changes. |
| | Detection Limits | The boundaries of what can be resolved or sensed by current instruments or methods. | Limited by spatial/temporal resolution, fluorophore brightness, photobleaching, probe insertion artifacts, background autofluorescence, low-abundance proteins, transient curvature events, weak ion flux signals, and small raft microdomain sizes. |
| 2.2 Measurement Systems | Units | Standardized quantifications (meters, seconds, volts, decibels, dollars, etc.) necessary for consistent comparison. | Fluorescence (a.u.), diffusion coefficients (µm²/s), membrane potential (mV), ion concentrations (nM–mM), lipid composition (%), curvature metrics (1/nm), conductance (pS), vesicle size (nm–µm), time (ms–min). |
| | Instruments | Devices and tools (microscopes, spectrometers, sensors, surveys, detectors) used to produce measurements. | Confocal microscopy, super-resolution microscopy (STED/STORM/SIM), TIRF microscopy, FRAP systems, FRET microscopes, cryo-EM, AFM, patch-clamp rigs, lipidomics mass spectrometers, membrane-tension sensors, microfluidic membrane platforms. |
| 2.3 Operational Definitions | Definitions | Terms defined by specific measurement procedures, ensuring empirical clarity. | Fluidity defined via diffusion coefficients; raft domains defined by phase-specific markers; membrane potential defined by voltage-sensitive dyes or electrodes; curvature inferred from shape metrics; permeability defined by solute flux. |
| | Procedures | The explicit steps required to perform a measurement in a reproducible way. | Membrane staining, liposome/SLB preparation, protein reconstitution, FRAP bleaching/measurement cycles, FRET-pair calibration, patch-clamp setups, lipid extraction, lipidomics workflows, vesicle-budding assays. |
| 2.4 Data Acquisition | Protocols | Formal processes for gathering data under controlled or standardized conditions. | Time-lapse imaging of domains/trafficking, FRAP time courses, FRET efficiency scans, ion-flux recordings, AFM surface scans, cryo-EM tilt-series, lipidomic MS runs, microfluidic bilayer-permeability assays. |
| | Sampling | Rules determining which subset of the domain is measured and how representative it is. | Multiple ROIs per cell, biological replicates, replicate bilayers/liposomes, multi-timepoint sampling, domain-size sampling across membranes, single-vesicle sampling, membrane-protein stoichiometry sampling. |
| 2.5 Data Character & Format | Data Types | The form raw evidence takes (time series, spectra, images, counts, qualitative records). | Fluorescence images/movies, FRAP curves, FRET efficiencies, AFM height maps, cryo-EM density maps, lipidomics tables, patch-clamp current traces, permeability curves, vesicle-size distributions. |
| | Resolution | The granularity or precision with which data is captured. | Determined by optical resolution, detector sensitivity, frame rate, probe response kinetics, EM voxel resolution, AFM tip geometry, MS peak resolution, and membrane heterogeneity. |
| 2.6 Reliability & Calibration | Calibration | Adjustment procedures ensuring instruments produce accurate results. | Fluorescence calibration (intensity/bleaching correction), FRET spectral unmixing, patch-clamp calibration, AFM cantilever calibration, lipidomics mass calibration, dye partition calibration, bilayer-thickness referencing. |
| | Error Characterization | Identification and quantification of noise, uncertainty, bias, and measurement error. | Photobleaching, probe-induced perturbation, membrane tension artifacts, dye toxicity, spectral bleed-through, mis-segmentation of domains, EM ice-thickness artifacts, ion-leak pathways, sample heterogeneity, and noise in MS-based lipid quantification. |
| 3. Structural Layer | 3.1 Patterns & Regularities | Laws / Relations | Stable, repeatable patterns governing how observables behave across conditions. | Fluid-mosaic principles, lipid-phase behavior (gel ↔ liquid-ordered ↔ liquid-disordered), curvature–composition coupling, domain formation rules, transport gating laws, membrane-potential relationships, lipid–protein cooperativity patterns, leaflet asymmetry stability. |
| | Invariants | Quantities or properties that remain constant under transformations (symmetries, conservation laws). | Conserved bilayer structure, invariant leaflet asymmetry in eukaryotic plasma membranes, stable transmembrane helix orientations, recurring channel/pump architectures, conserved lipid A, cardiolipin placement in energy membranes, preserved curvature-inducing motifs. |
| 3.2 Causal Architecture | Mechanisms | Underlying processes or structures that produce the observed regularities. | Lipid–protein interactions, ion pumping, transporter cycling, vesicle budding/fusion (SNARE, coat proteins), raft nucleation, membrane deformation by BAR proteins, flip–flop mechanisms, gating of channels, proton/ion gradient formation. |
| | Pathways | Organized sequences of interactions forming a causal chain or network. | Endocytosis/exocytosis, ER–Golgi trafficking, membrane-protein insertion pathways, lipid synthesis → transport → remodeling cycles, mitochondrial inner-membrane bioenergetic cycles, autophagosome formation, secretory pathways. |
| 3.3 Theoretical Vocabulary | Concepts | Core terms that encode the domain’s structure (force, gene, equilibrium, field). | Fluidity, curvature, lipid rafts, membrane tension, asymmetry, permeability, lateral diffusion, phase separation, transmembrane topology, gating, proton motive force, surface charge, leaflet coupling, bending rigidity, hydrophobic mismatch. |
| | Classifications | Taxonomies, categories, or typologies that organize entities and relations. | Membrane-protein classes (channels, pumps, receptors), lipid types (phospholipids, sphingolipids, sterols), membrane domains (rafts, caveolae), trafficking routes, transport mechanisms (passive, active, facilitated), curvature-generating proteins. |
| 3.4 Formal Representations | Equations | Mathematical constructs expressing laws, relations, or mechanisms. | Nernst equation (ion gradients), Goldman–Hodgkin–Katz equation, Helfrich curvature energy equation, diffusion equations (D = µm²/s), membrane-potential equations, partition/permeability equations, transport-rate equations for carriers/pumps. |
| | Models | Structured representations—mathematical, computational, or conceptual—used to predict and explain phenomena. | Fluid-mosaic model, raft models, membrane elastic models, coarse-grained MD simulations, membrane curvature/tension models, gating models for ion channels, carrier alternating-access models, fusion pore models. |
| 3.5 Idealized Structures | Simplified Models | Purposeful abstractions that capture essential dynamics while omitting irrelevant detail. | Perfectly homogeneous bilayers, symmetric leaflets, single-domain membranes, no protein clustering, ideal cylindrical micelles, simple flip–flop, linear diffusion, no cytoskeletal coupling, static tension. |
| | Limit Conditions | Regimes where specific models or approximations hold (classical vs. quantum, linear vs. nonlinear). | Break down in crowded membranes, high curvature, dynamic trafficking, cytoskeletal anchoring, domain-rich membranes, organelle-specific specializations (mitochondria, ER), rapid remodeling, or heterogeneous lipid mixing. |
| 3.6 Integrative Frameworks | Unifying Theories | Higher-order structures that connect disparate laws or mechanisms under a coherent whole. | Integration of lipid composition, membrane mechanics, protein distribution, transport energetics, and signaling into unified dynamic membrane frameworks; linking membrane structure ↔ function ↔ cellular physiology. |
| | Interdisciplinary Links | Points where the theory connects to adjacent sciences or larger explanatory systems. | Connects to biophysics, cell biology, structural biology, neurobiology, immunology, bioenergetics, materials science (lipid-based systems), and nanotechnology (liposomes, membrane mimetics). |
| 4. Method Layer | 4.1 Inquiry Design | Experimental Design | Structured plans for manipulating variables to test causal claims. | Controlling lipid composition, membrane-protein abundance, ion gradients, membrane potential, probe concentration, temperature, osmolarity, and trafficking stimuli to test membrane structure–function hypotheses. |
| | Observational Design | Systematic approaches for gathering non-manipulated data (surveys, field studies, natural experiments). | Monitoring spontaneous raft nucleation, natural curvature fluctuations, baseline ion leakage, endogenous trafficking events, unstimulated protein clustering, and passive diffusion without applying perturbations. |
| 4.2 Testing & Validation | Hypothesis Testing | Procedures for evaluating whether evidence supports or contradicts specific claims. | Comparing predicted diffusion rates, fluidity, rafts, transport activity, curvature changes, gating events, and protein–lipid interactions with experimental results from FRAP, FRET, patch-clamp, AFM, cryo-EM, and lipidomics. |
| | Replication | The requirement that results be independently reproducible under similar conditions. | Repeating FRAP recordings, FRET assays, patch-clamp runs, liposome reconstitutions, vesicle budding assays, cryo-EM grid preparations, and lipidomics extractions across biological and technical replicates. |
| 4.3 Inference & Evaluation | Statistical Inference | Rules for drawing conclusions from noisy or incomplete data. | Calculating diffusion coefficients, FRET efficiencies, gating probabilities, curvature distributions, domain sizes, conductance values, permeability constants, and confidence intervals for membrane biophysical parameters. |
| | Model Comparison | Criteria (fit, simplicity, predictive accuracy, robustness) used to evaluate competing models. | Evaluating fluid-mosaic vs raft models, diffusion vs active-transport frameworks, curvature–elasticity models, ion-channel gating models, and coarse-grained vs atomistic MD predictions. |
| 4.4 Error Management | Error Analysis | Identification and quantification of random and systematic errors. | Identifying photobleaching, probe-insertion artifacts, dye toxicity, membrane rupture, seal instability (patch-clamp), EM ice artifacts, MS ion suppression, segmentation errors, and motion blur in live-cell imaging. |
| | Bias Control | Methods for minimizing subjective, instrumental, or procedural biases. | Randomizing imaging fields, blinding sample identity, validating probe distribution, performing spectral unmixing, normalizing for protein expression, minimizing osmotic/mechanical stress, using orthogonal readouts. |
| 4.5 Adjudication & Revision | Peer Scrutiny | Collective evaluation of claims through critique, review, and debate. | Independent evaluation of membrane-domain assignments, transport-activity interpretations, curvature-mechanics conclusions, cryo-EM reconstructions, lipidomics quantitation, and gating/permeability model fits. |
| | Theory Revision | Procedures for modifying, replacing, or discarding models based on new evidence. | Updating models of membrane domain formation, lipid–protein interactions, curvature mechanics, transport energetics, gating mechanisms, and integrating new biophysical and structural evidence. |
| 4.6 Integrity Conditions | Transparency | Requirements to disclose methods, data, assumptions, and limitations. | Full reporting of probe concentrations, imaging settings, lipid-prep methods, calibration curves, segmentation parameters, lipidomics pipelines, and all data-processing and MD-simulation assumptions. |
| | Ethical Standards | Norms ensuring responsible conduct in experimentation, data handling, and publication. | Honest reporting of phototoxicity, probe interference, membrane damage, ambiguous domain boundaries, failed or unstable recordings, and adherence to biosafety requirements for membrane-active reagents and genetic manipulations. |